SEC Filing Summary for Invivyd, Inc.

Mina Michael, CMO and Chief Epidemiologist at Invivyd, Inc., acquired 1,125,000 stock options on July 31, 2026. These options, with an exercise price of $0.535, are for Invivyd's Common Stock. The options vest over a four-year period, with 25% vesting on the first anniversary of the grant date (July 31, 2026) and the remaining 75% vesting in monthly installments over the subsequent three years. The options expire on July 30, 2036. This transaction was reported on Form 4.